|
|
Arsanis announces closing of Initial Public Offering
Arsanis, Inc. (NASDAQ:ASNS) is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases. The gross proceeds to Arsanis from the offering were $46.0 million, before deducting underwriting discounts and commissions in addition to other offering expenses.
|
|
|
Themis raises € 10 million in series C financing
The GHIF-led investment will be used to advance Themis’s clinical and pre-clinical vaccine development programs, including its most advanced vaccine against chikungunya virus, on which the company recently reported positive Phase 2 results.
|
|
|
MEDICAL DEVICES, IVD & HEALTH CARE
|
|
New: Austrian BioImaging Industry Board (ABIB)
BioImaging Austria/CMI (Correlated Multimodal Imaging Node Austria) has established an Industry Board to connect all stakeholders interested in bioimaging and image processing in Austria. Concerted efforts and activities among life scientists, imaging scientists, computer experts, and the industry will foster multimodal imaging and drive innovation.
|
|
|
ImageBiopsy Lab collaborates with Image Analysis Group
New therapeutic approaches such as stem cell and gene therapy are driving the need for a standardized, objective and reproducible assessment of X-ray data. ImageBiopsy Lab and Image Analysis Group (IAG) have joined forces to integrate machine learning into clinical research on osteoarthritis (OA).
|
|
|
SzeleSTIM to be granted H2020 phase 1 SME support
SzeleSTIM is focusing on wearable bio-electronic devices for Auricular Vagus Nerve Stimulation, allowing minimally invasive and non-pharmacological pain therapy adapted to the individual patient. The new grant will contribute to disrupting the global electroceutical market.
|
|
|
TissueGnostics significantly expands its operations in the Far East
The new office in Hong Kong serves 14 countries in the Asia-Pacific region and collaborates with distributors in six additional countries and regions. This will boost high content and/or high throughput scanning and analysis of a broad range of microscopy samples in the Far East.
|
|
|
GMI to publish landmark study on an extracellular network map
MedUni Vienna to coordinate the EU-funded PECUNIA research program on standardized costing and outcome measures for optimized national healthcare provision within the EU
St. Anna Kinderkrebsforschung to start the liquid biopsy-based project “VISIOMICS” for the early prognosis of relapses in neuroblastoma patients
TU Wien: Allan Hanbury becomes the endowed professor to teach data intelligence
Uni Vienna: New approach in immune therapy to prevent tumor growth
|
|
Read more news at www.lisavienna.at.
|
|
Our news
Life Sciences Survey 2018 about to start
On behalf of BMDW, the Life Science Austria experts at aws have commissioned BIOCOM to create a new survey on life sciences in Austria. Please fill in the online form that you will receive in the next few weeks so that robust data and up-to-date input for the Austrian Life Sciences Directory can be made available by this fall!
Moreover, a new Vienna Life Science Report will be generated from this survey and selected profiles will also have the chance to be displayed at the Vienna Business Agency technology platform.
Boehringer Ingelheim Office Hours in Vienna on April 19, 2018
In collaboration with LISAvienna, Boehringer Ingelheim invites innovative biomedical start-ups and entrepreneurs to join the next BI Office Hours at the Vienna BioCenter. This is a great opportunity to benefit from BI’s science and business know-how. Please submit your meeting request by March 25, 2018 at the latest.
|
Meet LISAvienna
HIMSS 2018
Las Vegas, March 5-9, 2018
BIO-Europe Spring 2018
Amsterdam, March 12-14, 2018
Register as soon as possible!
MT-CONNECT and MedTech Summit 2018
Nuremburg, April 11-12, 2018
BioTrinity 2018
London, April 23-25, 2018
conhIT - Connecting Healthcare IT
Berlin, April 25-27, 2018
Bio€quity Europe
Ghent, May 14-16, 2018
HIMSS Europe 18 & Heath 2.0 Conference
Sitges, Barcelona, May 27-29, 2018
This list is not exhaustive and we reserve the right to make changes.
|
|
Latest Publication
Our media partner Chemiereport is featuring young life sciences start-ups in Vienna. Enjoy the reading!
|
|
|
More publications are available at www.lisavienna.at
|
|
Vienna Business Agency: FemPower IT 2018
Supports R&D projects in the IT sector under female management, demonstrating extensive female participation or incorporating gender mainstreaming
Max. funding amount: €500,000 per project; Bonus for women: €10,000
Deadline for submitting proposals: April 17, 2018
Vienna Business Agency: Call for Exhibits for the Vienna Research Festival
The Vienna Research Festival will take place from September 14-16, 2018 and for additional nine days, a special program for school classes will be offered. This will be a great opportunity to introduce your R&D to some 10,000 participants. Please submit your proposal for an interactive display by March 9, 2018.
|
|
OPEN CALLS and DEADLINES
March 9, 2018: Vienna Business Agency – Exhibits for the Vienna Research Festival
March 15, 2018: Vienna Business Agency - Shared Facilities
March 30, 2018: FFG - COIN Networks
April 12, 2018: WWTF – Cognitive Sciences Call 2018
April 17, 2018: Vienna Business Agency – FemPower IT 2018
If you would like to keep up with international funding opportunities, especially those at the EU level, you are invited to register at lifesciences.europa@ffg.at to enjoy a free mailing service. The most recent update is available here.
|
|
Find additional deadlines at www.lisavienna.at
|
|
March 5, 2018, FFG, Sensengasse 1, 1090 Vienna
Please register in gold time.
|
|
June 18-20, 2018, Vienna BioCenter, Campus-Vienna-Biocenter 1, 1030 Vienna
Deadline for the PhD workshop: May 4, 2018
|
|
June 25-26, 2018, Austria Trend Hotel Savoyen Vienna, Rennweg 16, 1030 Vienna
Please note the deadline for abstract submission: April 2, 2018
|
|
For more events be invited to www.lisavienna.at.
|
|
Your news placed here: Vienna-based organizations are invited to e-mail news and press releases to news@LISAvienna.at to contribute to LISAvienna's digital and print media.
Stay updated: Follow us on Twitter and LinkedIn and recommend our newsletter to colleagues and friends.
|
|
|
|
|
|